The science of skin repair is at the forefront of regenerative medicine. Whether used for burn victims, chronic wound healing, diabetic ulcers, or reconstructive surgery, skin grafts represent one of the most important intersections of biomaterials engineering, tissue regeneration, and clinical care.
U.S.-based companies continue to lead the way in developing engineered skin substitutes, acellular dermal matrices, and cell-based grafting technologies that accelerate healing while reducing complications. In this post, we spotlight 7 top biomaterials engineering companies innovating in this space.
1. Organogenesis Inc.
Headquarters: Canton, MA
🔬 Main Product Line:
- Apligraf® – Bilayered bioengineered skin substitute
- Dermagraft® – Cryopreserved human fibroblast-derived dermal substitute
- PuraPly® AM and PuraPly® XT – Antimicrobial wound matrices
✅ Pros:
- Apligraf is one of the first FDA-approved living skin equivalents with both dermal and epidermal layers, containing living human cells.
- Dermagraft helps regenerate native dermis by releasing growth factors and cytokines.
- PuraPly products provide antimicrobial action, ideal for chronic or infected wounds.
📈 Future Growth Prospects:
Organogenesis is expanding aggressively into outpatient wound care markets, partnering with hospitals and home-health providers. With increasing demand for chronic wound solutions in aging populations, their product portfolio is positioned for strong long-term growth.
2. Avita Medical
U.S. Headquarters: Valencia, CA
🔬 Main Product Line:
- RECELL® System – Autologous cell harvesting device for spray-on skin therapy
✅ Pros:
- RECELL enables rapid processing of a small skin sample into a sprayable suspension of skin cells used for burn treatment, significantly reducing the need for traditional grafts.
- Used by burn centers and the U.S. Department of Defense, with proven outcomes in severe burns and scar reduction.
- Minimally invasive and highly scalable.
📈 Future Growth Prospects:
With growing FDA indications and a strong pipeline for aesthetic, trauma, and vitiligo applications, Avita is poised to be a leader in point-of-care regenerative skin therapies, particularly in military and civilian trauma care.
3. MediWound Ltd. (U.S. Subsidiary)
U.S. Location: Paramus, NJ
Origin: Israel
🔬 Main Product Line:
- EscharEx® – Enzymatic debridement for chronic wounds
- NexoBrid® – Biologic debriding agent for severe burns
✅ Pros:
- NexoBrid enzymatically removes eschar (dead tissue) without harming healthy tissue, improving outcomes prior to skin grafting.
- Supports graft integration by preparing clean, vascularized wound beds.
- Backed by BARDA (U.S. Biomedical Advanced Research and Development Authority) for emergency use.
📈 Future Growth Prospects:
MediWound’s enzymatic technology offers an adjunctive and preparatory role for skin grafts. With FDA approvals expanding, the company is tapping into a wound care market expected to reach $30B+ by 2030.
4. Vericel Corporation
Headquarters: Cambridge, MA
🔬 Main Product Line:
- Epicel® – Cultured epidermal autografts for severe burns
- MACI® (for cartilage repair, but uses similar autologous tissue engineering)
✅ Pros:
- Epicel is FDA-approved for life-threatening full-thickness burns, created from a patient’s own keratinocytes cultured into large sheets of skin.
- Offers permanent epidermal coverage with minimal donor site requirements.
- Often used in conjunction with dermal matrices or scaffolds.
📈 Future Growth Prospects:
Vericel’s cell therapy manufacturing expertise positions it well as autologous grafting becomes more mainstream. With growing demand from burn centers and Level 1 trauma hospitals, the company is investing in bioreactor tech and automated manufacturing to meet rising needs.
5. Integra LifeSciences
Headquarters: Princeton, NJ
🔬 Main Product Line:
- Integra® Dermal Regeneration Template (IDRT)
- Integra® Bilayer Matrix Wound Dressing
- Omnigraft® Dermal Regeneration Matrix
✅ Pros:
- Integra pioneered acellular dermal matrix (ADM) technology, widely used in burns, reconstructive surgery, and diabetic foot ulcers.
- IDRT consists of a collagen-glycosaminoglycan matrix overlaid with a silicone layer to guide regeneration.
- Used in both inpatient surgical and outpatient wound settings.
📈 Future Growth Prospects:
Integra is expanding into robot-assisted surgery, neurosurgical biomaterials, and global trauma care, while continuing to enhance its skin substitute technologies. Their strategic focus on regenerative scaffolds and hybrid matrices will drive continued innovation.
6. MiMedx Group, Inc.
Headquarters: Marietta, GA
🔬 Main Product Line:
- EpiFix® – Dehydrated Human Amnion/Chorion Membrane (dHACM) allograft
- AmnioFix®, EpiCord® – Placental-derived grafts
✅ Pros:
- Products contain a rich matrix of growth factors, cytokines, and ECM proteins to accelerate healing.
- Placental-derived tissue avoids immunogenicity and provides natural regenerative cues.
- Ready-to-use, shelf-stable grafts simplify logistics and reduce surgical time.
📈 Future Growth Prospects:
MiMedx is advancing clinical trials for musculoskeletal and diabetic indications, while expanding market penetration in outpatient wound care. As placental allografts gain clinical traction, the company’s leadership in non-cellular biologics could reshape wound healing standards.
7. PolarityTE Inc.
Headquarters: Salt Lake City, UT
🔬 Main Product Line:
- SkinTE® – Autologous skin construct derived from a small skin sample
✅ Pros:
- SkinTE is a point-of-care, full-thickness skin construct created from a patient’s own tissue, designed to regenerate all layers of skin.
- Supports natural skin regeneration without immunosuppression.
- Early data suggest promising results for chronic wounds, surgical wounds, and trauma.
📈 Future Growth Prospects:
PolarityTE is developing automated tissue-processing systems, with FDA clearance paths underway. As personalized regenerative medicine becomes a priority, SkinTE’s approach aligns with the trend toward patient-specific, in-hospital solutions.
🧠Final Thoughts
The field of biomaterials for skin regeneration is evolving rapidly—from living cell-based grafts to decellularized scaffolds and sprayable autologous solutions. These seven U.S. companies are leading the charge, offering products that blend biology, engineering, and clinical usability.
As the burden of burn injuries, chronic wounds, and diabetic ulcers continues to rise, these innovations offer not just healing—but hope. For students and professionals in biomedical engineering, tissue engineering, and clinical research, these companies provide rich case studies, career opportunities, and collaboration prospects.
📬 Add Your Company to the Directory
Are you working on next-gen skin graft technologies? Submit your company listing for free at BioMedEngineerDirectory.com and help build the web’s most trusted biomedical innovation network.
🎥 Explore More on YouTube
Check out our YouTube Channel for skin graft technology explainers, interviews with biomedical engineers, and career guidance in regenerative medicine. Subscribe today!
📬 Have Questions or Ideas?
We’d love to hear from you! Whether you’re a student, educator, or industry professional, feel free to contact us with your questions, suggestions, or collaboration opportunities.
